RICHLAND, WA / ACCESSWIRE / April 19, 2018 / IsoRay, Inc. (NYSE American: ISR), a medical technology company
and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck
and gynecological cancers, today announced that it will present at the Planet MicroCap Showcase at 11:00 am PST on Wednesday, April
25, 2018 and will conduct 1on1 meetings on April 26, 2018.
The conference will be held April 24-26, 2018 at the Planet Hollywood Resort & Casino in Las Vegas, NV, 3667 S Las Vegas Blvd.,
Las Vegas, NV 89109. For those interested in meeting with management of IsoRay, please contact Robert Kraft at rkraft@snnwire.com (424) 227-9018, or visit www.planetmicrocapshowcase.com for more information.
About IsoRay, Inc.
IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds, which are
expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the
many benefits and uses of Cesium-131 by visiting www.isoray.com. Join us on
Facebook/IsoRay. Follow us on Twitter@IsoRay.
About Planet MicroCap Showcase
Planet MicroCap Showcase brings together promising companies with well-known/influential microcap investors, fund managers and
newsletter writers for three days of company presentations, one-on-one meetings, and networking in the nation's #1 destination for
meetings and entertainment.
If you would like to attend the Planet MicroCap Showcase, please send an email to rkraft@snnwire.com or call (424) 227-9018.
News Compliments of ACCESSWIRE.
Contacts:
IsoRay Inc.
info@isoray.com
(509) 375-1202
Investors:
Stephanie Prince, Managing Director
PCG Advisory Group
sprince@pcgadvisory.com
(646) 762-4518
SOURCE: IsoRay, Inc.
